Analysis of Metabolic Differences of Major Alkaloids From Corydalis Decumbentis Rhizoma in Normal and Gut Microbiota‐Depleted Rats Based on UPLC‐QTOF‐MS/MS
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Xiaoshuang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Gastrointestinal Microbiome, Alkaloids, Corydalis. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
The primary active constituents in Corydalis Decumbentis Rhizoma (Xiatianwu, XTW) are isoquinoline alkaloids, which generally exhibit low oral bioavailability. This low bioavailability suggests that these compounds may be metabolized by gut microbiota prior to absorption. However, the characteristics of gut microbiota‐mediated metabolism of XTW in vivo remain unclear. This study employed ultra‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry (UPLC‐QTOF‐MS/MS) to identify prototype compounds and metabolites of XTW in rat feces. The metabolic profiles of XTW between the control and pseudo‐germ‐free (GF) rats were systematically analyzed to delineate the gut microbiota‐mediated metabolic profile of XTW in rat feces. In the control group, 92 compounds were identified, with 70 of them categorized as metabolites. In the pseudo‐GF group, 80 compounds were identified, among which 44 compounds were categorized as metabolites. The significant reduction in metabolite diversity in the pseudo‐GF group indicates that gut microbiota‐mediated metabolism was suppressed. Moreover, the levels of certain prototype alkaloids and Phase I metabolites were significantly lower in the pseudo‐GF group, while Phase II metabolites were compensatorily increased. The findings demonstrate that suppression of the gut microbiota alters the in vivo metabolism of XTW. These findings provide new evidence for understanding the role of gut microbiota in the metabolism of XTW.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
ORCID-Profile: Yingyuan Lu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Li, X., Ou, L., Zhang, W., Chen, S., Lu, Y., & Tu, P. (2026). Analysis of Metabolic Differences of Major Alkaloids From Corydalis Decumbentis Rhizoma in Normal and Gut Microbiota‐Depleted Rats Based on UPLC‐QTOF‐MS/MS. Biomedical Chromatography. https://doi.org/10.1002/bmc.70289
Vancouver
Li X, Ou L, Zhang W, Chen S, Lu Y, Tu P. Analysis of Metabolic Differences of Major Alkaloids From Corydalis Decumbentis Rhizoma in Normal and Gut Microbiota‐Depleted Rats Based on UPLC‐QTOF‐MS/MS. Biomedical Chromatography. 2026. doi:10.1002/bmc.70289
BibTeX
@article{Li2026,
author = {Li, Xiaoshuang and Ou, Lu and Zhang, Wenxin and Chen, Sijian and Lu, Yingyuan and Tu, Pengfei},
title = {Analysis of Metabolic Differences of Major Alkaloids From Corydalis Decumbentis Rhizoma in Normal and Gut Microbiota‐Depleted Rats Based on UPLC‐QTOF‐MS/MS},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70289}
}
EUVIMED